Macro partitioning
Bariatric surgery leads to greater long-term weight loss and better glycemic control (lower HbA1c, HOMA-IR) compared to conventional medical therapy in severely obese T2DM patients, with specific surgical types (RYGB, BPD) showing superior metabolic effects.
Bariatric surgery provides superior long-term weight loss and blood sugar control compared to medication alone for severely obese diabetics. The specific type of surgery (e.g., RYGB vs. BPD) influences which metabolic markers improve most, so discussing these differences with a healthcare provider is important for personalized treatment.
the results demonstrate that bariatric surgery is associated with better weight and better glycemic control over the long-term than non-surgical therapies, and reveal that different surgical methods have different effects on various metabolic indicators.
Why this rating
Meta-analysis of multiple studies showing consistent trends in weight and glucose metrics.
Source
Long-term outcomes of macrovascular diseases and metabolic indicators of bariatric surgery for severe obesity type 2 diabetes patients with a meta-analysis
Guoli Yan et al. · PLoS ONE · 2019
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →